Upgrade

ENDRA Life Sciences Inc.

NDRA

Last
$5.46
Day
-7.9%
1y
-12.9%
5y
-100.0%
52w
-39.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
5.88
EMA 50
5.56
EMA 200
10.69
20d high
-11.1%
5y high
-100.0%
5y range
0th
Website · 9 employees · United States

Positions held

Your positions

NDRA isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
28
Hold
swing
Signal
Buy
Target
$6.76
Stop
$5.24
Stop distance
4.0%
Target vs last
+23.8%

Fundamentals

Market cap$8.89MEnterprise value$7.58MTrailing P/E—Forward P/E-1.95
PEG—Price / book1.41Beta-0.08Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-1.5%ROA-77.3%Debt / equity0.07
Current ratio7.10Free cash flow-$6.73MAnalyst recommendationnoneMean target$25.00
52w high$9.8552w low$2.96

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income$0.2M-$1.3M-$3.2M-$1.6M-$1.2M—
Gross margin——————
Gross profit——————
Operating income-$1.5M-$2.2M-$1.6M-$1.4M-$1.3M—

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$7.0M-$11.5M-$10.1M-$13.2M—
Gross margin—————
Gross profit————$0.0M
Operating income-$5.8M-$10.8M-$10.5M-$13.2M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

NDRA · daily-4.8% over 13 sessions
Close EMA21 EMA50 EMA200
5.635.906.176.456.722026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$3M-$2M-$2M-$1M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2